Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus
- 1 February 1995
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 4 (1) , 29-32
- https://doi.org/10.1177/096120339500400107
Abstract
We investigated a possible association between markers of immune activation and disease activity in 52 patients with systemic lupus erythematosus (SLE). Serum concentrations of neopterin, beta- 2-microglobulin, 55 kD-type soluble tumor necrosis factor receptor, soluble interleukin-2 receptor and soluble CD8 were compared to the Index of European Consensus Lupus Activity Measurement (ECLAM). All markers of immune activation, except sCD8, significantly correlated with ECLAM. Stepwise multiple linear regression analysis revealed erythrocyte sedimentation rate and neopterin to correlate best with ECLAM (multiple correlation coefficient = 0.74, P < 0.001). The study shows that serum neopterin concentrations are a useful independent index for disease activity in SLE. The finding of enhanced concentrations of various parameters of immune activation in patients confirm a role of the T cell and macrophage activation in the pathogenesis of SLE.Keywords
This publication has 21 references indexed in Scilit:
- Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight lossEuropean Journal Of Cancer, 1993
- Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1993
- Elevated Serum Neopterin Levels in Acute Rheumatic FeverPteridines, 1993
- Cytokine abnormalities in human lupusClinical Immunology and Immunopathology, 1992
- POSTTRANSPLANT NEOPTERIN EXCRETION IN RENAL ALLOGRAFT RECIPIENTS—A RELIABLE DIAGNOSTIC AID FOR ACUTE REJECTION AND A PREDICTIVE MARKER OF LONG-TERM GRAFT SURVIVALTransplantation, 1991
- Immune activation and the anaemia associated with chronic inflammatory disordersEuropean Journal of Haematology, 1991
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Neopterin as a marker for activated cell-mediated immunity: Application in HIV infectionImmunology Today, 1988
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitisArthritis & Rheumatism, 1982